Saturday, July 15, 2017 | London, UK
This workshop will introduce the National Institutes of Health (NIH) sponsored Alzheimer's Disease Related Dementia (ADRD) FTD activities to the larger research community. The workshop will focus on genetic approaches for identifying new gene mutations, genetic modifier identification, data availability, cohort studies and emerging technologies. Ongoing efforts in Parkinson's Disease (PD), Alzheimer's Disease (AD) and FTD sequencing will be presented and a panel discussion will focus on collaborative efforts going forward. Clinical trial preparation will be discussed specifically in reference to the use of genetics in FTD clinical trials.